<DOC>
	<DOCNO>NCT01553006</DOCNO>
	<brief_summary>Cefditoren pivoxil use rhinosinusitis treatment . However , little known efficacy drug low high dos .</brief_summary>
	<brief_title>Study Cefditoren Pivoxil Treatment Childhood With Acute Rhinosinusitis</brief_title>
	<detailed_description>The investigation randomize , investigator-blinded , parallel study , conduct patient ( age 1-15 year ) acute rhinosinusitis . Two group patient randomize receive low ( 10 MKD ) high ( 20 MKD ) drug 14 day . Changes sinus symptoms score , response rate adverse effect evaluate day 7 14 . Relapse rate record day 21 28 . Recurrence sinus symptom day 60 assess .</detailed_description>
	<mesh_term>Sinusitis</mesh_term>
	<mesh_term>Cefditoren</mesh_term>
	<mesh_term>Cefditoren pivoxil</mesh_term>
	<mesh_term>Cephalosporins</mesh_term>
	<criteria>child age 115 year old diagnose acute rhinosinusitis poor compliance infection</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>rhinosinusitis</keyword>
	<keyword>cefditoren pivoxil</keyword>
</DOC>